Robert Aspbury
Corporate Officer/Principal bei CERTARA, INC.
Vermögen: 5 Mio $ am 30.04.2024
Profil
Robert P.
Aspbury is currently the President-Certara Scientific Software at Certara, Inc. Prior to his current position, he worked as the Vice President-Strategic Solutions at Labcorp Drug Development, Inc. from 2016 to 2019.
He holds a doctorate degree from The University of Liverpool, which he obtained in 1995.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CERTARA, INC.
0,18% | 01.04.2024 | 290 176 ( 0,18% ) | 5 Mio $ | 30.04.2024 |
Aktive Positionen von Robert Aspbury
| Unternehmen | Position | Beginn |
|---|---|---|
| CERTARA, INC. | Corporate Officer/Principal | 01.01.2020 |
Ehemalige bekannte Positionen von Robert Aspbury
| Unternehmen | Position | Ende |
|---|---|---|
| COVANCE INC. | Corporate Officer/Principal | 01.03.2019 |
Ausbildung von Robert Aspbury
| The University of Liverpool | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Private Unternehmen | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
